28.22 USD
↗ 2.88 (11.37%)AT CLOSE (11:59 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
27.50
↘ 0.72 (2.55%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
27.50
↘ 0.72 (2.55%)
Market: CLOSED
GH Research PLC Ordinary Shares (GHRS) trades at $28.22 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Jun 26, 2026.
Open?$25.08
High?$28.32
Low?$25.08
Prev. Close?$25.34
Volume?275.6K
Avg. Volume?N/A
VWAP?$27.23
Bid / Ask
Bid?$22.61 × 100
Ask?$31.92 × 100
Spread?$9.31
Midpoint?$27.27
Valuation & Ratios
Market Cap?1.7B
Shares Out?68.6M
Float?45.2M
Float %?72.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?218.65Safe
Confidence?31%Very Low
Short InterestHigh
Short % of Float?4.48%Low
Short Interest?2.0M
Days to Cover?8.1
Free Float45.2M
Avg Daily Volume250.2K
Settlement Date2026-06-15